发明名称 Aryl-substituted alicyclic compound and medical composition comprising the same
摘要 An aryl-substituted alicyclic compound of the formula (I): wherein U is 1,4,5,6-tetrahydropyrimidin-2-yl, etc., A is phenylene, etc., B is piperidine-1,4-diyl, etc., Z is -CONH-, etc., R<SUP>3 </SUP>is hydrogen, etc., R<SUP>5 </SUP>is hydrogen, aryl, etc., R<SUP>6 </SUP>is a mono-substituted amino (e,g., benzyloxycarbonylamino), R<SUP>7 </SUP>is hydrogen, etc., and a process for preparation thereof, and a pharmaceutical composition containing the same. The compound of the present invention has a high selectivity for alphavbeta3 integrin, and exhibits a potent inhibitory activity thereto, and hence, it is useful as a preventive or/and a therapeutic agent for a disease in which alphavbeta3 integrin is involved.
申请公布号 US7176199(B2) 申请公布日期 2007.02.13
申请号 US20030472236 申请日期 2003.09.22
申请人 DAINIPPON PHARMACEUTICAL CO., LTD. 发明人 MORIE TOSHIYA;IWAMA SEIJI;NOTAKE MITSUE;KITANO TOMOKO
分类号 C07D239/14;A61K31/445;A61K31/4545;A61K31/497;A61K31/506;A61K31/551;A61P9/00;A61P9/10;A61P17/06;A61P19/00;A61P19/02;A61P19/08;A61P19/10;A61P27/02;A61P29/00;A61P31/12;A61P35/00;A61P35/04;A61P37/00;A61P43/00;C07D211/62;C07D233/50;C07D239/16;C07D239/42;C07D295/185;C07D401/04;C07D401/12;C07D401/14;C07D413/14 主分类号 C07D239/14
代理机构 代理人
主权项
地址